{"id":"oxytetracycline-taro-elixir","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Nausea"},{"rate":"5-10%","effect":"Vomiting"},{"rate":"5-10%","effect":"Diarrhea"},{"rate":"5-10%","effect":"Abdominal pain"},{"rate":"1-5%","effect":"Allergic reactions"}]},"_chembl":{"chemblId":"CHEMBL1517","moleculeType":"Small molecule","molecularWeight":"460.44"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"This binding prevents the attachment of aminoacyl-tRNA to the ribosomal acceptor site, thereby inhibiting peptide bond formation and ultimately leading to the death of the bacterial cell. Oxytetracycline is effective against a wide range of bacteria, including those that cause respiratory tract infections, skin infections, and gastrointestinal infections.","oneSentence":"Oxytetracycline is a broad-spectrum antibiotic that inhibits protein synthesis by binding to the 30S ribosomal subunit.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:25:10.360Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Respiratory tract infections"},{"name":"Skin infections"},{"name":"Gastrointestinal infections"}]},"trialDetails":[{"nctId":"NCT01032499","phase":"PHASE3","title":"Open and Comparative Study to Measure Tolerability and Efficacy of Taro Elixir","status":"UNKNOWN","sponsor":"Laboratorios Goulart S.A.","startDate":"2010-05","conditions":"Acne Vulgaris II or III Degree, Boils","enrollment":120}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"oxytetracycline, taro elixir","genericName":"oxytetracycline, taro elixir","companyName":"Laboratorios Goulart S.A.","companyId":"laboratorios-goulart-s-a","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Oxytetracycline, taro elixir is a small molecule that inhibits the bacterial 70S ribosome. It is used to treat conditions such as acne vulgaris II or III degree and boils, as demonstrated in clinical trials.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}